Biotech 2050 Podcast

Biotech 2050 Podcast

Biotech2050 Podcast is a think tank chronicling the disruptions changing the biotech industry over the next 50 years.

Tämä podcast on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi podcastin jaksot saattavat sisältää mainontaa.

Jaksot(265)

16. Mike Novotny, Founder and CEO, Medrio

16. Mike Novotny, Founder and CEO, Medrio

Mike Novotny is the founder and CEO of Medrio. Mr. Novotny applies 20 years of experience in research and software to his eClinical SaaS vision. Prior to founding Medrio, Mr. Novotny was president of ...

3 Kesä 202034min

15. David Mace, Co-Founder and CEO, SwiftScale Biologics

15. David Mace, Co-Founder and CEO, SwiftScale Biologics

David Mace is the Co-founder & CEO of SwiftScale Biologics, a life sciences startup based in San Francisco, California. SwiftScale Biologics accelerates time to market for protein drugs by turning a l...

27 Touko 202029min

14. David Bates, PhD, Co-Founder, Linus Health

14. David Bates, PhD, Co-Founder, Linus Health

David Bates is a scientist, inventor, investor, and entrepreneur. He has co-founded several companies including Linus Health and Bode. He is a founding partner of Tamarisc Ventures and serves on the b...

20 Touko 202034min

13. Stephan Kontos, PhD, Co-Founder and CSO, Anokion

13. Stephan Kontos, PhD, Co-Founder and CSO, Anokion

Stephan is a co-Founder and Chief Scientific Officer at Anokion, bringing more than 15 years of research expertise in the fields of immunology, protein engineering, and platform technologies to the co...

13 Touko 202031min

12. Robert Gould, PhD, President & CEO, and Owen Wallace, PhD, CSO, Fulcrum Therapeutics

12. Robert Gould, PhD, President & CEO, and Owen Wallace, PhD, CSO, Fulcrum Therapeutics

Robert J. Gould joined Fulcrum as president and CEO at the time of the company’s launch in 2016, bringing over 30 years of experience to the role. Previously, he served as president and CEO of Epizyme...

4 Touko 202033min

11. Controllable cell and gene therapies, Paul Wotton, PhD, CEO, Obsidian Therapeutics

11. Controllable cell and gene therapies, Paul Wotton, PhD, CEO, Obsidian Therapeutics

Dr. Paul K. Wotton is the Chief Executive Officer at Obsidian Therapeutics. Obsidian is a biotechnology company pioneering controllable cell and gene therapies to deliver transformative outcomes for p...

27 Huhti 202029min

10. Chris Murray, Sr. VP, Technical Operations, Blueprint Medicines

10. Chris Murray, Sr. VP, Technical Operations, Blueprint Medicines

Chris is Sr. Vice President, Technical Operations at Blueprint Medicines. He has over 25 years of commercial and clinical manufacturing experience in the biopharmaceutical industry and has been fortu...

26 Helmi 202032min

9. The next frontier in cancer treatment: Foghorn Therapeutics and Chromatin Dysregulation

9. The next frontier in cancer treatment: Foghorn Therapeutics and Chromatin Dysregulation

Carl P. Decicco is a biopharmaceutical veteran with over 30+ years of experience in the industry. Over the course of his career, Carl has played a central role in the advancement of more than 200 comp...

23 Tammi 202027min

Suosittua kategoriassa Tiede

rss-mita-tulisi-tietaa
rss-poliisin-mieli
utelias-mieli
rss-hereilla
tiedekulma-podcast
rss-duodecim-lehti
rss-luontopodi-samuel-glassar-tutkii-luonnon-ihmeita
docemilia
rss-bios-podcast
hippokrateen-vastaanotolla
rss-ranskaa-raakana
rss-lihavuudesta-podcast
rss-radplus
rss-politiikasta-podcast
radio-antro
rss-tiedetta-vai-tarinaa